Why a 1% Price Increase Beats a 1% Cost Cut by 4x to EBITDA
Cost cutting produces real margin, but it has a ceiling, and the ceiling arrives faster than most operating partners expect. This guide covers the commercial levers that keep delivering margin after the cost work runs out of room.
The Operator's Guide to EBITDA Margin Improvement
Every PE thesis has an EBITDA number. Every operating partner has six months before the board asks how the number is tracking. The default instinct is cost reduction, because costs are concrete and cutting them feels like action.
Briar & Westfall Capital closed on Clearpoint Data, a $42M ARR infrastructure monitoring company, with a thesis that called for 5 points of EBITDA expansion over a four-year hold. Starting margin: 18%. Target: 23%. The operating partner, Dara, spent the first four months the way most operating partners do. Software consolidation. Vendor renegotiation. Real estate footprint reduction. She recovered 1.8 points. Clean work. No muscle cut.
Then the cost budget ran out of room.
The remaining 3.2 points had to come from commercial expansion, and that expansion took twelve months to install. The portcos that deliver top-quartile EBITDA outcomes at exit start the commercial work early. The portcos that miss the number are still cutting costs in year three, running out of things to cut.
TL;DR
- Cost cutting produces real margin. It also has a ceiling, and the ceiling arrives faster than most operating partners expect. The first 1-2 points come from cost reduction. The remaining 2-5 points have to come from commercial expansion
- The fastest commercial lever is discount governance: a deal desk threshold at 10%, enforced without exception, that recovers 2-4% of margin within one quarter
- NRR is an EBITDA lever, not a CS metric. Every 1 point of NRR improvement at a $40M ARR portco produces $400K of annual recurring revenue at near-100% incremental margin
- The best operators compete on discipline, not instinct. Discounting is usually a symptom. Pricing maturity is measured by what you stop doing
The core problem: the cost ceiling arrives in month six
The thesis modeled a 5-point EBITDA expansion over a four-year hold. At Clearpoint Data's $42M ARR with a starting 18% margin, that equaled roughly $2.1M of annual margin to produce, compounding across the hold.
Dara delivered the first 1.8 points through cost reduction: $420K in software consolidation, $180K in vendor renegotiation, $160K in real estate savings. After that, the cost budget had no muscle-free cuts left. The next cost move would have meant headcount in revenue-generating functions, which would have shown up as EBITDA in the model and revenue loss in the P&L.
The remaining 3.2 points had to come from seven commercial levers. Dara sequenced them in order of speed and structural difficulty.
Seven commercial levers for EBITDA expansion
Lever 1: Start with pocket price, not list price
Every portco has a pocket-price gap. Pocket price is the revenue collected after all discounts, credits, allowances, and concessions are applied. The gap between list and pocket is the sharpest margin recovery move because it does not require a price increase, only enforcement of the price already set.
Dara pulled the last 90 days of billing data at Clearpoint and measured the dollar gap between list and pocket for the top 50 accounts. The average gap was 14.3%. The policy said 10%. Nobody was enforcing the policy.
Asking the CFO for "a pricing review" and getting a slide about list prices is the common failure mode. Pocket price is a different analysis. It has to be requested specifically.
Lever 2: Fix discounting before raising price
A 5% list price increase absorbed by 6% additional discounting produces net-negative margin. The governance has to precede the raise.
Dara installed deal desk sign-off at Clearpoint. Every discount above 10% required CRO approval with a documented rationale. Pocket price was reported weekly alongside bookings. The CRO was held accountable for pocket price realization, not bookings alone.
The temptation to raise list in the first 120 days "to send a signal" before the governance is in place is strong. At Clearpoint, a competitor had done exactly that. Their reps absorbed the raise through larger discounts, and pocket price moved by zero. Dara held the list price steady for six months, fixed the floor, and then raised the ceiling. Pocket price realization improved 3.1 points in the first two quarters, worth $1.3M annually.
Lever 3: Treat NRR as an EBITDA lever
Every 1 point of NRR improvement at Clearpoint's $42M ARR produced $420K of annual recurring revenue at near-100% incremental margin. NRR belongs in the EBITDA plan, not in a quarterly CS review the operating partner does not attend.
Dara set an NRR target alongside new-bookings targets and built a retention scorecard into the monthly operating review. The CS leader was held accountable for NRR, not for "customer health scores." Logo retention can stay flat while NRR declines, and the declining NRR is the EBITDA leak. At Clearpoint, logo retention was 91%. NRR was 98%. The gap told the story: accounts were staying but shrinking. Four points of NRR improvement over the next year added $1.7M to the run rate.
Lever 4: Re-tier packaging to capture value already delivered
Most portcos bundle features at the wrong tier. Enterprise features sit in the Pro tier. Nobody upgrades because the Pro tier already includes what they need.
Dara audited feature adoption by tier at Clearpoint. The advanced alerting engine, which cost $1.2M annually to run and had been the most requested feature in the prior year, was included in the standard tier. Forty-three percent of standard-tier customers used it weekly. There was no upgrade path because there was no reason to upgrade. It was already included.
The fix was a packaging restructure: advanced alerting moved to an enterprise tier with a clear upgrade path and a quantifiable reason to move (SLA guarantees, priority support, custom alert rules). Repackaging without usage data is the failure mode. The team has to know what customers use, what customers value, and where the gap between the two creates a tier boundary. Within three quarters, the enterprise tier grew from 11% to 24% of the customer base, adding $2.4M in ARR at 88% incremental margin.
Lever 5: Govern renewal pricing as aggressively as new sales
Renewals are where quiet margin erosion happens. A three-year renewal with a 12% "loyalty discount" is an EBITDA event that never appears on any dashboard as one.
At Clearpoint, Dara required executive sign-off on renewal discounts above 7%. Renewal net ACV was reported alongside logo retention. Account managers were trained to present renewals as value conversations, not discount negotiations.
Letting account managers handle renewals unsupervised because "they own the relationship" is the common failure mode. At Clearpoint, the relationship had been costing 9% of renewal margin on average. The relationship still exists. The ungoverned discount does not.
Lever 6: Separate the cost stack from the commercial stack in the board view
If the EBITDA plan blends cost and commercial levers, the sequencing gets muddled and the board cannot see which bets are working.
Dara built a two-column plan: cost actions with 12-month impact, commercial actions with 18-36-month impact. The board reviewed both separately. A single "EBITDA improvement" bucket that makes every initiative look interchangeable is the failure mode. The timelines and risks are different. Mixing them produces a plan that looks complete and is operationally incoherent.
Lever 7: Review the EBITDA plan against commercial leading indicators
EBITDA is a trailing metric. By the time the EBITDA result shows up, the commercial decisions that drove it are 6-9 months old.
Dara added pocket-price realization, NRR, and pipeline coverage to the monthly operating partner dashboard. Drift in the leading indicators was treated as an early EBITDA warning. Reviewing EBITDA monthly without the commercial leading indicators alongside is how you find out too late to correct.
Three failure modes
Over-indexing on cost in year one. A $70M ARR portco spent 14 months cutting vendor contracts and had no commercial headroom left when growth flattened. By the time the operating partner pivoted to commercial levers, the hold was half over.
Raising list before fixing leakage. A $45M ARR portco raised list 6% and saw pocket price decline 2% because reps discounted harder to protect quota. The net margin impact was 4%, not the 6% the model showed. Fix the floor before you raise the ceiling.
Treating renewals as administrative. A $25M ARR portco quietly lost 9% of renewal ACV to "loyalty discounts" that no single executive approved. The discounts accumulated deal by deal, invisible until Dara's team pulled the renewal-level data.
The 30-60-90 sprint
Days 1-30. Pull pocket-price realization for the largest portco and identify the three biggest leakage sources. Set an NRR target for every portco and add it to the monthly operating partner review. Separate the cost stack from the commercial stack in the next board deck. Do not raise prices yet. Make the gap visible.
Days 31-60. Install deal desk governance with a 10% discount threshold and CRO sign-off. Audit the last 20 renewals above $100K for unapproved discounts. Audit feature adoption by tier and identify the packaging mismatch. Report pocket price weekly alongside bookings. NRR goes into the commercial review, not the CS review.
Days 61-90. Run the first quarterly EBITDA review with commercial leading indicators alongside the cost stack. Measure pocket-price recovery, NRR trajectory, and tier-upgrade rates. At Clearpoint, the 90-day readout showed 3.1 points of pocket-price recovery, an NRR trajectory from 98% to 102%, and the enterprise tier growing from 11% to 17% of the base. Combined with the 1.8 points of cost reduction, the total EBITDA improvement was on track to exceed the 5-point thesis target by the end of year two.
FAQ
Why is commercial-led EBITDA expansion better than cost-led? Cost-led expansion is finite. You can cut only so much before you start removing capability. Commercial-led expansion, through pricing governance and NRR improvement, compounds across the hold period. A 1% list-price increase typically drops 8-11% to EBITDA. A 1% cost reduction drops 2-3%. The ceiling on commercial work is much higher.
What is the fastest EBITDA lever in the first six months? Discount governance. A deal desk threshold at 10%, enforced without exception, typically recovers 2-4% of margin within one quarter. No product change, no list price move, no headcount decision.
How do you know if an EBITDA target is commercial or structural? If the thesis called for expansion above 5 points, at least half has to be commercial. Cost alone cannot produce 5-point expansion in most mid-market portcos without breaking the operating model.
What EBITDA moves should operating partners avoid in the first year? Aggressive list price increases without deal desk governance. Headcount cuts in revenue-generating functions. Cross-selling programs launched before product telemetry is installed. These moves look like EBITDA in the model and show up as revenue loss in the P&L.
How does NRR contribute to EBITDA expansion? Every 1 point of NRR improvement at a $40M ARR portco produces $400K of annual recurring revenue at near-100% incremental margin. NRR is an EBITDA lever, not a CS metric.
Why does raising list price before fixing discount leakage destroy margin? A 5% list price increase absorbed by 6% additional discounting produces net-negative margin. Reps compensated on bookings will give back the list increase to protect quota. Fix the floor before you raise the ceiling.
Run the free assessment or book a consultation to apply this framework to your specific situation.
Questions, answered
6 QuestionsWhy does commercial-led EBITDA expansion outperform cost-led inside a PE hold?
Cost-led expansion is finite. You can cut only so much before you start removing capability. Commercial-led expansion, done through pricing governance and NRR improvement, compounds across the hold period. A 1% list-price increase typically drops 8-11% to EBITDA. A 1% cost reduction drops 2-3%. The ceiling on commercial work is much higher.
What's the fastest EBITDA lever an operating partner can pull in the first 6 months?
Discount governance. A deal desk threshold at 10%, enforced without exception, typically recovers 2-4% of margin within one quarter. No product change, no list price move, no headcount decision. It is the single most effective action an operating partner can take in the first six months.
How do you know if an EBITDA expansion target requires commercial or structural levers?
If the thesis called for EBITDA expansion above 5 points during the hold, at least half of that has to be commercial. Cost alone cannot produce 5-point expansion in most mid-market portcos without breaking the operating model. The moment you push past what costs can reasonably deliver, you are implicitly committing to commercial expansion.
Which EBITDA moves should PE operating partners avoid in the first year of a hold?
Aggressive list price increases without deal desk governance. Headcount cuts in revenue-generating functions. Cross-selling programs launched before product telemetry is installed. These moves look like EBITDA in the model and show up as revenue loss in the P&L.
How does NRR translate into EBITDA expansion at a $40M ARR portco?
Every 1 point of NRR improvement at a $40M ARR portco produces $400K of annual recurring revenue at near-100% incremental margin. NRR is an EBITDA lever, not a CS metric. The portcos that treat it as both grow margin while growing revenue, which is the compounding effect that makes commercial-led expansion worth the longer timeline.
Why does raising list price before fixing discount leakage produce a net-negative margin result?
A 5% list price increase absorbed by 6% additional discounting produces net-negative margin. Reps compensated on bookings will give back the list increase to protect quota. The governance has to precede the raise. Fix the floor before you raise the ceiling.
Cost cutting produces real margin, but it has a ceiling, and the ceiling arrives faster than most operating partners expect. This guide covers the commercial levers that keep delivering margin after the cost work runs out of room.
How relevant and useful is this article for you?
About the Author(s)
Emily Ellis is the Founder of FintastIQ. Emily has 20 years of experience leading pricing, value creation, and commercial transformation initiatives for PE portfolio companies and high-growth businesses. She has previous experience as a leader at McKinsey and BCG and is the Founder of FintastIQ and the Growth Operating System.
References
- William Thorndike. The Outsiders. Harvard Business Review Press, 2012
- Eileen Appelbaum & Rosemary Batt. Private Equity at Work. Russell Sage Foundation, 2014
- Michael Marn, Eric Roegner & Craig Zawada. The Price Advantage. Wiley, 2004
- Bain & Company. Global Private Equity Report. Bain & Company, 2024
- McKinsey & Company. The Power of Pricing. McKinsey Quarterly, 2003
